Belgium· BE-AMP-SAM583235-00
Cresnisol N18
A aminosäuren product containing leucine, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Aminosäuren is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Aminosäuren · ATC B05BA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Leucine
- Manufacturer
- Baxter
- Country
- Belgium (BE)
- ATC code
- B05BA01
- ATC class
- Aminosäuren
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for aminosäuren.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aminosäuren · interactions on record
4 records
- 4 moderate
Most severe, free to view
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- MetamfetamineN06BA03moderate
- LisdexamfetamineN06BA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aminosäuren in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f84f20f-aaff-4a1e-8aa0-2b8ed5d43d76 GET /v1/drugs/5f84f20f-aaff-4a1e-8aa0-2b8ed5d43d76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Cresnisol N18",
"name_fr": "Cresnisol N18",
"name_nl": "Cresnisol N18",
"amp_code": "SAM583235-00",
"strengths": [
"7.6800",
"7.6800",
"1.8500",
"1.8500",
"7.6800",
"7.6800",
"6.6000",
"6.6000",
"4.3800",
"4.3800",
"10.9000",
"10.9000"
],
"pack_count": 2,
"substances": [
"Leucine",
"Tryptophan",
"Glycine",
"Histidine",
"Serine",
"Arginine",
"Valine",
"Threonine",
"Lysine",
"Methionine",
"Isoleucine",
"Phenylalanine",
"Proline",
"Aspartic Acid",
"Alanine",
"Tyrosine",
"Glutamic Acid",
"Lysine Acetate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Amino Acids",
"authorisation_numbers": [
"BE583244",
"BE583235"
]
}See everything about aminosäuren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.